 This trial tests the feasibility of enrolling 60 extremely preterm infants in a randomized, double-blinded study of blood pressure management within 12 months. Eligible infants will receive an infusion drug dopamine or a dextrose placebo and a syringe drug hydrocortisone or a normal saline placebo. 